Search

everythinglearnresearchcommunity

for

Search:↓

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

N-acetylcysteine improved symptoms of trichotillomania and bulimia.

The microbiome may be linked to hair loss and could be a target for new treatments.

A young woman with late-stage Vogt-Koyanagi-Harada disease was successfully treated at a hospital.

Nutrease powder, a high-protein, low-carb supplement, can help manage Polycystic Ovary Syndrome symptoms, regulate periods, improve ovulation, and restore fertility.

Human hair keratins can self-assemble and support cell growth, useful for biomedical applications.

The document concludes that atopic dermatitis in dogs is managed with various treatments including antipruritics, supplements, and possibly immunotherapy.

The document is a detailed medical reference on skin and genetic disorders.

The document is a detailed guide on skin conditions and treatments for dermatologists.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

Exosomes show promise for tissue repair and regeneration with advantages over traditional cell therapies.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

The document explains various skin conditions and their treatments.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

The article concludes that understanding the causes of hair loss and using continuous treatments like minoxidil and finasteride can help manage it, despite potential side effects.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

The document concludes that there have been significant improvements in diagnosing and treating skin diseases, including melanoma, with new techniques and therapies.

Classifying hair diseases, like alopecia, is difficult and needs more research to understand their causes.

The document concludes that new treatments for skin conditions are complex but effective, including spironolactone for female hair loss and propranolol for infantile hemangiomas.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Botulinum toxin type A reduces itch and inflammation from histamine and may help treat certain skin conditions and hair loss.

Botulinum toxin A helped stop hair loss and grow new hair in mice.

Different botulinum toxin products and concentrations can effectively reduce sweating, itching, bladder pressure, hair loss, and muscle spasms.

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.